IL34246A - Hexahydro-2h-indeno(1,2-c)-pyridine derivatives,their preparation and pharmaceutical compositions containing them - Google Patents

Hexahydro-2h-indeno(1,2-c)-pyridine derivatives,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL34246A
IL34246A IL34246A IL3424670A IL34246A IL 34246 A IL34246 A IL 34246A IL 34246 A IL34246 A IL 34246A IL 3424670 A IL3424670 A IL 3424670A IL 34246 A IL34246 A IL 34246A
Authority
IL
Israel
Prior art keywords
indeno
hexahydro
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL34246A
Other languages
English (en)
Other versions
IL34246A0 (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH525869A external-priority patent/CH513864A/de
Priority claimed from CH691169A external-priority patent/CH517744A/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL34246A0 publication Critical patent/IL34246A0/xx
Publication of IL34246A publication Critical patent/IL34246A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Catalysts (AREA)
IL34246A 1969-04-08 1970-04-06 Hexahydro-2h-indeno(1,2-c)-pyridine derivatives,their preparation and pharmaceutical compositions containing them IL34246A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
CH525869A CH513864A (de) 1969-04-08 1969-04-08 Verfahren zur Herstellung neuer Indenopyridinderivate
CH691169A CH517744A (de) 1969-05-06 1969-05-06 Verfahren zur Herstellung neuer Indenopyridinderivate
CH889169 1969-06-11
CH914569 1969-06-16
CH1361069 1969-09-09
CH1837969 1969-12-10
CH1842269 1969-12-11

Publications (2)

Publication Number Publication Date
IL34246A0 IL34246A0 (en) 1970-06-17
IL34246A true IL34246A (en) 1973-02-28

Family

ID=27561104

Family Applications (1)

Application Number Title Priority Date Filing Date
IL34246A IL34246A (en) 1969-04-08 1970-04-06 Hexahydro-2h-indeno(1,2-c)-pyridine derivatives,their preparation and pharmaceutical compositions containing them

Country Status (9)

Country Link
JP (1) JPS4815943B1 (ro)
CA (1) CA955260A (ro)
DK (1) DK130292B (ro)
FI (1) FI52976C (ro)
IE (1) IE34654B1 (ro)
IL (1) IL34246A (ro)
NL (1) NL166019C (ro)
NO (1) NO133401C (ro)
RO (1) RO58032A (ro)

Also Published As

Publication number Publication date
NO133401C (ro) 1976-04-28
DK130292C (ro) 1975-06-30
CA955260A (en) 1974-09-24
JPS4815943B1 (ro) 1973-05-18
NO133401B (ro) 1976-01-19
RO58032A (ro) 1975-06-15
FI52976C (ro) 1978-01-10
IE34654L (en) 1970-10-08
FI52976B (ro) 1977-09-30
NL7004461A (en) 1970-10-12
IL34246A0 (en) 1970-06-17
IE34654B1 (en) 1975-07-09
NL166019B (nl) 1981-01-15
NL166019C (nl) 1981-06-15
DK130292B (da) 1975-02-03

Similar Documents

Publication Publication Date Title
IL35668A (en) Xanthone derivatives,their preparation and pharmaceutical compositions containing them
IL35781A0 (en) New derivatives of aminopropiophenone,their preparation and pharmaceutical compositions containing them
IL35688A (en) Substituted n-allyl-2-arylamino-imidazolines-(2),their preparation and pharmaceutical compositions containing them
ZA704481B (en) Tetrahydropyrido-thioxanthene derivatives,compositions containing them,and preparation thereof
IL33846A0 (en) Derivatives of 1-thiachromone and 4-thionchromone,their preparation and pharmaceutical compositions containing them
IL33925A0 (en) Acetyl-guanidine derivatives,their preparation and pharmaceutical compositions containing them
IL34173A0 (en) Imidazolidinone derivatives,their preparation and pharmaceutical compositions containing them
IL33626A0 (en) Benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them
IL35689A0 (en) 2-arylamino-imidazolines-(2),their preparation and pharmaceutical compositions containing them
IL34328A (en) Isoquinoline derivatives,their preparation and pharmaceutical compositions containing them
IL34771A (en) 2,4,5-tribromoimidazole derivatives,their preparation,and pesticidal compositions containing them
IL35490A (en) 6-amidino-penicillanic acid derivatives,their preparation and pharmaceutical compositions containing them
IL34947A0 (en) Pyridobenzodiazepin-6-one derivatives,their preparation and pharmaceutical compositions containing them
IL35779A (en) 4-amino-quinazoline derivatives,their preparation and pharmaceutical compositions containing them
IL35211A0 (en) 4-aryl-4-hydroxy-piperidine derivatives,their preparation and pharmaceutical compositions containing them
IL33745A0 (en) Phenylserine derivatives,their preparation and pharmaceutical compositions containing them
IL33821A (en) 1,3-dihydro-5-phenyl or pyridyl-2h-1,4-benzodiazepin-2-onederivatives,their preparation and pharmaceutical compositions containing them
IL35204A0 (en) Derivatives of 4-amino-2-methylpyrimidine,their preparation and pharmaceutical compositions containing them
IL34317A0 (en) Substituted acetamides,their preparation and pharmaceutical compositions containing them
IL34086A0 (en) Triazole derivatives,their preparation and pharmaceutical compositions containing them
IL34271A0 (en) Benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them
IL33993A0 (en) Aminopropiophenones,their preparation and pharmaceutical compositions containing them
IL34246A0 (en) Hexahydro-2h-indeno(1,2-c)-pyridine derivatives,their preparation and pharmaceutical compositions containing them
IL34788A0 (en) 10,11-dihydrodibenzoazepine derivatives,process for their preparation and compositions containing them
IL33961A0 (en) Benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them